Healthcare facilities often screen new technology for cost benefit and improved clinical outcomes before deciding to invest and acquire expensive technology. USTR works with facility purchasing groups to identify and screen new technology for the facility. These technologies are purchased by the facility as a capital expense. These items are then placed on the facility purchasing schedule. If bundled as a hospital expense there is one payment for all products and services commensurate with the use of that technology. For medicare reimbursement USTR will ascertain if the facility will save money by implementation of this new technology.
USTR will work with insurance companies to achieve acceptance and reimbursement of cost effective new technology
USTR will create cutting edge technology marketing tools for consumers, providers and payors highlighting the clinical outcome of the new technology used by the facility.
